Accelerated & Efficient Drug Development

Minerva Imaging is a scientifically driven CRO founded in 2011.
Our focus is on the use of advanced oncology models and molecular imaging for translational cancer research and drug development.

Our services

Oncology

We have extensive experience in design and execution of pre-clinical studies for drug development within oncology.

Read more

Radionuclide Therapy

We have substantial experience in performing studies with targeted radionuclide therapy in oncology.

Read more

Molecular Imaging

Building on more than two decades of research in Nuclear Medicine we are proficient in conducting molecular imaging.

Read more

Cardiovascular Disease

We have in-depth knowledge in cardiovascular disease and advanced imaging to study drug interventions.

Read more

We engage with our clients to understand their scientific questions and discuss how our methods and capabilities can provide answers.

Optimal results require attention to details

We engage with our clients to understand their scientific questions and discuss how our methods and capabilities can provide answers. Our competences build on more than two decades of research within oncology and molecular imaging performed at the University of Copenhagen and Rigshospitalet, the National University Hospital of Denmark.

Read about us

Latest news

February 17th 2020

New publication on PET imaging

Quantitative PET imaging of PD-L1 expression in xenograft and syngeneic tumour models

Read story
November 5th 2019

PRESS RELEASE: Minerva Imaging acquires BioAdvice

Minerva Imaging ApS has acquired BioAdvice A/S.  

Read story
October 17th 2019

Minerva Imaging is presenting at the AACR-NCI-EORTC 2019

Minerva Imaging is presenting at the AACR-NCI-EORTC Conference 2019

Read story
September 27th 2019

Meet us at the EANM Congress 2019

Minerva Imaging will be available for meetings at the EANM Congress 2019 in Barcelona, Spain

Read story